Evaluation of Novel N‐(piperidine‐4‐yl)benzamide Derivatives as Potential Cell Cycle Inhibitors in HepG2 Cells

Publisher: John Wiley & Sons Inc

E-ISSN: 1747-0285|86|2|223-231

ISSN: 1747-0277

Source: CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol.86, Iss.2, 2015-08, pp. : 223-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract